ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 397–408 of 2020 project topics
Predictive Analytics Tool for Newborn Screening Risk Stratification
A proprietary analytics engine that uses population genetics data and clinical biomarkers to predict disease progression and outcome severity in screened newborns with actionable risk scores. This tool creates B2B revenue opportunities through licensing to pediatric hospitals, state health departments, and insurance companies seeking cost-effective early intervention strategies.
Newborn Genetic Screening Programs Click to view more details →
Mobile Patient Portal for Newborn Screening Result Management
A consumer-facing mobile application and web platform that delivers secure newborn screening results, educational content, and appointment scheduling to parents and healthcare providers in real-time. The platform monetizes through freemium subscription tiers, integration fees from healthcare systems, and partnerships with prenatal testing companies and pediatric care providers.
Newborn Genetic Screening Programs Click to view more details →
Comparative Genomics Database and Benchmarking Service Platform
A commercial cloud-based repository containing aggregated newborn screening data from thousands of institutions enabling labs to benchmark their performance metrics and identify optimization opportunities. This B2B service generates recurring revenue through database licensing, premium analytics features, and consulting services for laboratory quality improvement initiatives.
Newborn Genetic Screening Programs Click to view more details →
Regulatory Compliance Management System for Screening Programs
A comprehensive compliance software tool that tracks regulatory requirements, documentation standards, and quality metrics across federal, state, and international newborn screening guidelines. The platform delivers value through subscription licensing to screening programs and labs while reducing compliance audit costs and enabling seamless regulatory reporting across jurisdictions.
Newborn Genetic Screening Programs Click to view more details →
Familial Hypercholesterolemia LDLR Variant Analysis
Characterizing pathogenic variants in LDLR, APOB, and PCSK9 causing familial hypercholesterolemia and developing comprehensive genetic testing strategies.
Genetic Basis of Cardiovascular Disease Click to view more details →
Inherited Cardiomyopathy Gene Panel Testing
Developing diagnostic panels for hypertrophic, dilated, and arrhythmogenic cardiomyopathy genes for cascade testing in affected families.
Genetic Basis of Cardiovascular Disease Click to view more details →
Long QT Syndrome Genetic Diagnosis
Characterizing KCNQ1, KCNH2, and SCN5A variants in long QT syndrome for genotype-guided risk stratification and prophylactic treatment decisions.
Genetic Basis of Cardiovascular Disease Click to view more details →
Stroke Genetic Risk Factor Identification
Using GWAS and rare variant studies for identifying genetic factors predisposing to ischemic and hemorrhagic stroke in diverse populations.
Genetic Basis of Cardiovascular Disease Click to view more details →
Arrhythmogenic Right Ventricular Cardiomyopathy Genetic Screening Platform
A SaaS diagnostic platform that identifies pathogenic variants in ARVC-associated genes (DSP, PKP2, DSG2) through automated variant interpretation and phenotype matching. This platform enables cardiology clinics and laboratories to offer rapid risk stratification services, generating revenue through per-test subscriptions and premium clinical reporting features.
Genetic Basis of Cardiovascular Disease Click to view more details →
Atrial Fibrillation Polygenic Risk Score Commercial Calculator
An enterprise tool that aggregates multiple genetic risk variants associated with atrial fibrillation susceptibility to compute personalized polygenic risk scores for patient stratification. Healthcare providers license this tool to identify high-risk populations for preventive interventions, creating recurring SaaS licensing revenue and patient management upsell opportunities.
Genetic Basis of Cardiovascular Disease Click to view more details →
Familial Aortic Aneurysm Mutation Detection and Counseling Suite
An integrated commercial solution combining genetic testing for FBN1, TGFBR1, and TGFBR2 mutations with automated clinical decision support and family risk communication tools. The platform monetizes through direct-to-consumer testing kits, healthcare provider licensing, and premium genetic counselor collaboration modules.
Genetic Basis of Cardiovascular Disease Click to view more details →
Myocardial Infarction Early-Onset Genetic Risk Prediction Engine
A machine learning-powered diagnostic tool that analyzes multi-gene variants (LDLR, APOB, APOE, LIPA) to predict premature MI risk in individuals under 55 years old. Insurance companies and preventive cardiology programs deploy this engine to identify intervention-eligible populations early, driving premium pricing through improved risk stratification.
Genetic Basis of Cardiovascular Disease Click to view more details →